Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Wendy B. Young currently holds 13,289 shares of Rapport Therapeutics, Inc. (RAPP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Wendy B. Young has been a net buyer of RAPP stock. They have purchased $279.1K and sold $0 worth of shares.
Wendy B. Young's most recent insider trade was on Oct 22, 2026, when they purchased 3,789 shares at $26.39 per share.
Wendy B. Young serves as Executive at Rapport Therapeutics, Inc. (RAPP). They have executed 5 insider transactions totaling $279.1K over their tenure at the company.
Wendy B. Young holds the position of Executive at Rapport Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Wendy B. Young has shown a buying trading pattern, with $279.1K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Wendy B. Young was on Jun 12, 2026, when they purchased $100.0K worth of ADIL shares. This transaction involved 36,378 shares at $2.75 per share.
Wendy B. Young currently owns 13,289 shares of Rapport Therapeutics, Inc. (RAPP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Wendy B. Young's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Wendy B. Young has 5 Form 4 filings on record as an insider at Rapport Therapeutics, Inc..
Set alerts for Wendy B. Young and 40,000+ other insiders.